Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting

Acta Neurologica Scandinavica

Volumn 115, Issue 3, 2007, Pages 204-208

  Mohanraj, R ^a   Brodie, M J ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Antiepileptic drug; Idiopathic epilepsy; Prognosis; Risk factor; Syndrome

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEBRILE CONVULSION; FEMALE; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCLONUS EPILEPSY; OUTCOME ASSESSMENT; REMISSION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; EPILEPSY, GENERALIZED; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846852413     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00791.x     Document Type: Article

References (28)

1. COMMISSION ON CLASSIFICATION AND TERMINOLOGY OF THE INTERNATIONAL LEAGUE AGAINST EPILEPSY. Proposal for revised classification of epilepsy and epileptic syndromes. Epilepsia 1989;30:389-99.
2. SEMAH F, PICOT MC, ADAM C et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998;51:1256-62.
3. KWAN P, BRODIE MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
4. MOHANRAJ R, BRODIE MJ. Outcomes in newly diagnosed localization-related epilepsies. Seizure 2005;14:318-23.
5. NICOLSON A, APPLETON RE, CHADWICK DW, SMITH DF. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies. J Neurol Neurosurg Psychiatry 2004;75:75-9.
6. MOHANRAJ R, BRODIE MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 2006;13:277-82.
7. Commission on Classification and Terminology of the ILAE: proposal for revised clinical classification of epileptic seizures. Epilepsia 1981;22:489-501.
8. LOISEAU J, LOISEAU P, GUYOT M, DUCHE B, DARTIGUES JF, AUBLET B. Survey of seizure disorders in the French southwest. I. Incidence of epileptic syndromes. Epilepsia 1990;31:391-6.
9. ZARRELLI MM, BEGHI E, ROCCA WA, HAUSER WA. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984. Epilepsia 1999;40:1708-14.
10. GASTAUT H. Individualisation des épilepsies dites 'bénignes' ou 'fonctionnelles' ux différents ages de la vie. Appréciation des variations correspondantes de la rédisposition épileptique à ces ages. Rev EEG Neurophysiol 1981;11:346- 66.
11. PANAYIOTOPOULOS CP, KOUTROUMANIDIS M, GIANNAKODIMOS S, AGATHONIKOU A. Idiopathic generalized epilepsy in adults manifested by phantom absences, generalized tonic-clonic seizures, and frequent absence status. J Neurol Neurosurg Psychiatry 1997;63:622-7.
12. GILLIAM F, STEINHO BJ, BITTERMANN HJ, KUZNIECKY R, FAUGHT E, ABOU-KHALIL B. Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology 2000;55:1030-3.
13. NICOLSON A, CHADWICK DW, SMITH DF. A comparison of adult onset and "classical" idiopathic generalized epilepsy. J Neurol Neurosurg Psychiatry 2004;75:72-4.
14. CUTTING S, LAUCHHEIMER A, BARR W, DEVINSKY O. Adult-onset idiopathic generalized epilepsy: clinical and behavioural features. Epilepsia 2001;42:1395-8.
15. MARINI C, KING MA, ARCHER JS, NEWTON MR, BERKOVIC SF. Idiopathic generalized epilepsy of adult onset: clinical syndromes and genetics. J Neurol Neurosurg Psychiatry 2003;74:192-6.
16. CHAVES J, SANDER JW. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 2006;46(Suppl. 9):133-9.
17. THOMAS P, VALTON L, GENTON P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006;129:1281-92.
18. GUERRINI R, BELMONTE A, PARMEGGIANI L, PERUCCA E. Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 1999;21:420-4.
19. CRESPAL A, GENTON P, BERRAMDANE MP et al. Lamotrigine associated with exacerbations or de novo myoclonus in idiopathic generalized epilepsies. Neurology 2005;65:672-4.
20. BENBADIS SR, TATUM WO IV, FIERON M. Idiopathic generalized epilepsy and choice of antiepileptic drugs. Neurology 2003;61:1793-5.
21. HITIRIS N, BRODIE MJ. Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs. Epilepsia 2005;46(Suppl. 9):149-53.
22. FRENCH JA, KANNER AM, BAUTISTA J et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: reported of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:410-23.
23. BERGEY GK. Evidence-based treatment of idiopathic generalised epilepsies with new antiepileptic drugs. Epilepsia 2005;46(Suppl. 9): S161-8.
24. GLAUSER T, BEN-MENACHEM E, BOURGEOIS B et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug therapy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-120.
25. FERNANDO-DONGAS MC, RADTKE RA, VANLANDINGHAM KE, HUSAIN AM. Characteristics of valproic acid resistant juvenile myoclonic epilepsy. Seizure 2000;9:385-8.
26. GELISSE P, GENTON P, THOMAS P, REY M, SAMUELIAN JC, DRAVET C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001;70:240-3.
27. BAULAC S, GOURFINKEL-AN I, NABBOUT R et al. Fever, genes, and epilepsy. Lancet Neurol 2004;3:421-30.
28. MARINI C, SCHEER IE, CROSSLAND KM et al. Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia 2004;45:467-78.